Adapt ive Randomized Study of Idarubic in and Cytarabine Versus Troxaci tabine and Cytarabine Versus Troxaci tabine and Idarubic in in Untreated Pat ients 50 Years or Older With Adverse Karyotype Acute Myelo id Leukemia
暂无分享,去创建一个
D. Berry | E. Estey | J. Wathen | H. Kantarjian | G. Garcia-Manero | J. Cortes | S. Verstovsek | S. O'brien | F. Giles | Lianchun Xiao | S. Faderl | A. Ferrajoli | D. Thomas